◂ Announcements

Oct 27, 2023EXPANSIONCandiac, Québec, Canada

Pharmascience announces $120M expansion of Candiac injectable manufacturing facility

Pharmascience Inc. announced a $120 million expansion of its sterile injectable manufacturing facility in Candiac, Québec, supported by government partners. The project will triple injectable manufacturing capacity and is expected to come online in 2026.

Value

$120.0M

Starts operating

2026

Status

Announced

Capacity

triple its injectable manufacturing capacity

Productssterile injectable pharmaceuticals

CompaniesPharmascience

“This major expansion project is the continuation of Pharmascience's vision to be the Canadian leader in biomanufacturing of both generic and innovative products.”newswire.ca

1 source
newswire.caPHARMASCIENCE ANNOUNCES $120 MILLION EXPANSION OF CANDIAC INJECTABLE MANUFACTURING FACILITIESPharmascience Inc.Oct 27, 2023

Summarized from public sources; check the original articles before acting on it.

Loading…